Inovio Pharma (INO) Misses Q4 EPS by 65c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 -6.92%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.65). Revenue for the quarter came in at $120 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Infleqtion, Inc (INFQ) PT Raised to $22 at Citi
- Walmart shares fall despite earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
